This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Bovie Medical Corporation Comments On Recent Corporate Activities

Bovie Medical Corporation (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today commented on recent corporate activities.

Vessel Sealing Products

The Federal District Court Complaint, filed in Tampa, Florida against Steve Livneh, Lican Development, Ltd. and Henvil Corp. (both controlled by Mr. Livneh), was instituted to protect the Company and its shareholders from ongoing actions by the defendants that were considered damaging to Bovie’s best interests. Mr. Livneh was removed from the Board for cause at a Special Board Meeting held on July 16, 2010. Despite these unwelcome diversions, the Company proceeds with its vessel sealing product research and testing protocols necessary for the FDA 510K submission process. Developmental and engineering progress continues to be made while vice president of sales and marketing for surgical products, Jeff Rencher, prepares to market the Company’s vessel sealing products and other offerings.

Recent J-Plasma Developments

The Company is actively developing enhancements to its J-Plasma™ product, which leverage and combine unique properties of J-Plasma™ ionized helium gas together with surgical instrumentation under development. The enhancements are expected to have potential application to a broad variety of surgical procedures. The Company is coordinating with a number of leading university surgeons who will evaluate the J-Plasma™ enhancements in diverse surgical specialties. The Company is planning to file new patents related to these potential uses and intends to display its J-Plasma™ as well as other products at the 39 th AAGL Global Congress of Minimally Invasive Gynecology in Las Vegas November 8-12, 2010.

Sintered Steel

The Company continues to advance its Sintered Steel product lines, and while temporarily delayed by the Salient/Medtronic litigation, is moving forward with its SEER™ and BOSS™ marketing.

In Other News

Mr. Rencher, as part of market planning for all of Bovie’s specialty surgical products, foresees the addition of up to 100 independent sales representatives located throughout the United States during the next twelve months. Shipments of surgical products, including the recently released Bovie coated electrodes, will commence by month’s end to the new specialty sales reps. The Company also reports the extension of its OEM agreement with Medtronic Inc. through 2012.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,904.12 -15.47 -0.09%
S&P 500 1,981.60 +9.86 0.50%
NASDAQ 4,527.5140 +19.2020 0.43%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs